performed weekly drainage in all cases. Mean duration of catheter in place was 79 days. The maximum duration of catheter in place was 245 days. 30.3% of cases were removed catheter after lung expansion. 12% of cases were successfully performed talc pleurodesis as outpatient basis. Complications were transient and correctable. Pain was the predominant complication occurring in 10% of cases lasting 2 days and not required catheter removal for the resolution of discomfort. 6% of cases had empyema thoracis and 1% of cases had cellulitis. Both emyema and cellulitis were successfully treated with antibiotic. 98% of cases were satisfied with catheter stay in place.
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Conclusion: Indwelling pleural catheter placement is a useful tool for malignant or recurrent pleural effusion in low income country. It is safe and decreases dyspnic symptom and rate of hospitalization due to pleural effusion. Background and Aims: Background: The British Thoracic Society standards for bronchoscopy and EBUS suggest the quality of a service be measured by an "urgent" procedure (including suspected malignancy) being performed within 7 working days, whilst maintaining diagnostic rates for biopsies of >85% for bronchoscopy and >88% for linear EBUS-TBNA, particularly for malignancy.
Aims:
Primary -(i) Assess wait times for "urgent" procedures and
(ii) diagnostic rates for malignancy for bronchoscopy and linear EBUS-TBNA. Secondary -Assess the percentage of biopsy samples which were sufficient for further molecular testing for malignancy.
Methods: Prospective data collection for all patients undergoing bronchoscopy or EBUS over a 5 month period. Cases were followed up for 6 months to confirm a diagnosis of malignancy. Diagnostic rates were defined as 'patients diagnosed with malignancy from bronchoscopic or EBUS biopsy' divided by 'total patients with malignancy confirmed after 6 months follow up'.
Results: 102 bronchoscopy and 48 EBUS cases were performed.
Median wait time was 5 days for bronchoscopy and 6 days for EBUS. 56% of bronchoscopies were classified as urgent and 75% were performed within 7 days. Main reason for delay was proceduralist availability (50%). 90% of EBUS cases were classified as urgent and 65% were performed within 7 days. Main reason for delay was needing anaesthetist support (56%). Diagnostic rates for visible tumour with bronchoscopy was 45%, and there was significant variation in type and number of biopsies undertaken. Diagnostic rates for EBUS-TBNA was 92%. Suitable tissue for molecular testing was obtained in 91%.
Conclusion: Overall, only 60% of "urgent" procedures were performed within 7 days, falling short of current standards, highlighting the need for improved scheduling. Malignancy diagnostic rates and sampling adequacy for EBUS-TBNA meets current standards, however fibreoptic bronchoscopy appears to fall short. This may reflect variable sampling techniques during bronchoscopy and a need for standardisation. Slow growth rate, absence of haemoptysis, and central airway obstruction were observed as characteristics of benign bronchial tumours.
Methods:
We report a 69 year-old cirrhosis female with mild bronchiectasis developed recurrent haemoptysis of unknown aetiology. According to clinical presentation, physical exam, and lab data, no evidence of infection sign, upper airway bleeding, or bleeding tendency was noted. Chest X-ray did not reveal tumor, ground glass opacity, pulmonary edema, nodular lesion, or cardiomegaly either. Since reccurrent haemoptysis, chest computed tomography and flexible bronchoscopy were performed.
Results: Computed tomography showed no obvious lung or bronchial mass. However, one smooth, low vascularity, and soft mass lesion measured as 0.6 centimetre at the orifice of RB8 was found during white light bronchoscopy. Autofluorescence image from the same area was not notable for lack of autofluorescence. Biopsy reported bronchial tissue with submucosal nodular proliferation of intersecting fascicles of spindled tumoural cells with eosinophilic cytoplasm. Endobronchial leiomyoma was diagnosed.
Conclusion:
Since the tumor lie in the proximal part of right lower lobe, cryotherapy for tumor removal may be suitable for this patient. 
